<DOC>
	<DOC>NCT00940992</DOC>
	<brief_summary>To identify lowest efficacious dose of DER 45 EV Gel, 1% and 5% verses vehicle in patients with rosacea.</brief_summary>
	<brief_title>A Study of DER 45-EV Gel to Treat Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>Males and females, 18 years of age or older Facial rosacea, with 12 or more inflammatory lesions (with no more than 2 nodules) Mild, Moderate or Severe (2, 3 or 4) rating of rosacea on the IGA Females of childbearing potential must have negative urine pregnancy test result at baseline and must be willing to use an effective form of contraception throughout the study Subjects who are pregnant, breast feeding, or planning a pregnancy during the study Allergy or sensitivity to ingredients in test product Any dermatological conditions of the face that may interfere with study evaluations Subjects unable to avoid or minimize exposure to factors that may exacerbate or trigger rosacea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>